Pharmacyclics (PCYC) – Hot Corp. News
-
Pharmacyclics (PCYC) Reports IMBRUVICA Combo Phase 3 Met Primary Endpoint in CLL, SLL; Study Will be Unblinded
-
AbbVie (ABBV) to Acquire Pharmacyclics (PCYC) for $21 Billion
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PCYC Stock Lookup